Effect of growth factors in uterine lining during in vitro fertilizatio
Not Applicable
- Conditions
- Health Condition 1: N972- Female infertility of uterine origin
- Registration Number
- CTRI/2023/03/050711
- Lead Sponsor
- Indrakanti Naga Prathyusha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Thin endometrium patients in frozen embryo transfer cycles
2. Cleavage and blastocyst transfer
3. Basal serum FSH less than 10 IU/l
4. Having a least 1 or 2 good quality frozen embryos
Exclusion Criteria
1. Abnormalities of uterine shape
2. Endometriosis
3. Premature ovarian failure
4. Donor IVF
5. With bleeding disorders
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Endometrial thickness before and after ABCD <br/ ><br>2. Uterine biophysical profile before and after ABCDTimepoint: 1. Day of ABCD administration <br/ ><br>2. 5 days to 1 weeks after ABCD administration
- Secondary Outcome Measures
Name Time Method POSITIVE BETA HCG RATES <br/ ><br>POSITIVE CLINICAL PREGANANCY RATES <br/ ><br>POSITIVE LIVE BIRTH RATESTimepoint: 1. 2 weeks after embryo transfer <br/ ><br>2. 5 weeks after positive beta hcg <br/ ><br>3. 28 -40 weeks after positive clinical pregnancy